» Articles » PMID: 22488927

Plasmablast Frequency and Trafficking Receptor Expression Are Altered in Pediatric Ulcerative Colitis

Overview
Specialty Gastroenterology
Date 2012 Apr 11
PMID 22488927
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The incidence of pediatric ulcerative colitis (UC), a chronic autoinflammatory disease of the colon, is on the rise. Although an increased infiltration of B cells from the peripheral blood into the colon occurs in UC, B-cell trafficking is understudied. We hypothesized that the frequency of circulating plasmablasts (PBs) and their trafficking receptor (TR) expression may be indicative of the location and degree of pathology in pediatric UC.

Methods: We conducted multicolor flow cytometry analyses of circulating IgA(+/-) PBs and IgA(+) memory B cells (MBCs) in pediatric UC patients with remission, mild, moderate, and severe state of disease (n = 12), and healthy pediatric (n = 2) and adult donors (n = 11).

Results: Compared to healthy donors the average frequency of PBs among total peripheral blood lymphocytes is increased 30-fold during severe UC activity, and positively correlates with Pediatric Ulcerative Colitis Activity Index score, C-reactive protein level, and erythrocyte sedimentation rate. A greater percent of PBs in severe patients express the gut-homing receptors α4β7 and CCR10, and the inflammatory homing molecule P-selectin ligand (P-sel lig). The percent of IgA(+) MBCs expressing α4β7, however, is reduced. Furthermore, expression of the small intestine TR CCR9 is decreased on α4β7(high) PBs, and on α4β7(high) /CCR10(high) PBs and MBCs in these patients, consistent with preferential cell targeting to the colon.

Conclusions: Peripheral blood PBs with a colon-homing phenotype (α4β7/CCR10/P-sel lig) are elevated in children with severe UC. Screening this B-cell subset may provide a complementary approach in monitoring disease activity or therapeutic efficacy in pediatric UC.

Citing Articles

attenuates experimental mice colitis through modulating gut microbiota and immune responses.

Liu L, Xu M, Lan R, Hu D, Li X, Qiao L Front Immunol. 2022; 13:1036196.

PMID: 36531989 PMC: 9750758. DOI: 10.3389/fimmu.2022.1036196.


Clonal expansion and markers of directed mutation of IGHV4-34 B cells in plasmablasts during Kawasaki disease.

Chang A, Baron S, Hoffman J, Hicar M Mol Immunol. 2022; 145:67-77.

PMID: 35303530 PMC: 9166636. DOI: 10.1016/j.molimm.2022.03.011.


An autopsy case of acute myocarditis with unique lymph node findings characterized by the proliferation of reactive plasmablasts.

Ohtani H, Nozaki Y, Murakami T, Lin L, Shiono J, Miyazawa M J Clin Exp Hematop. 2020; 60(3):108-112.

PMID: 32981914 PMC: 7596914. DOI: 10.3960/jslrt.20023.


Antibodies and Immunity During Kawasaki Disease.

Hicar M Front Cardiovasc Med. 2020; 7:94.

PMID: 32671098 PMC: 7326051. DOI: 10.3389/fcvm.2020.00094.


Inherent Immune Cell Variation Within Colonic Segments Presents Challenges for Clinical Trial Design.

Tyler C, Guzman M, Lundborg L, Yeasmin S, Perez-Jeldres T, Yarur A J Crohns Colitis. 2020; 14(10):1364-1377.

PMID: 32239151 PMC: 7533898. DOI: 10.1093/ecco-jcc/jjaa067.


References
1.
Kantele A, Savilahti E, Tiimonen H, Iikkanen K, Autio S, Kantele J . Cutaneous lymphocyte antigen expression on human effector B cells depends on the site and on the nature of antigen encounter. Eur J Immunol. 2003; 33(12):3275-83. DOI: 10.1002/eji.200324311. View

2.
Schurmann G, Bishop A, Facer P, Vecchio M, Lee J, Rampton D . Increased expression of cell adhesion molecule P-selectin in active inflammatory bowel disease. Gut. 1995; 36(3):411-8. PMC: 1382456. DOI: 10.1136/gut.36.3.411. View

3.
Souza H, Elia C, Spencer J, MacDonald T . Expression of lymphocyte-endothelial receptor-ligand pairs, alpha4beta7/MAdCAM-1 and OX40/OX40 ligand in the colon and jejunum of patients with inflammatory bowel disease. Gut. 1999; 45(6):856-63. PMC: 1727744. DOI: 10.1136/gut.45.6.856. View

4.
Abitorabi M, Mackay C, Jerome E, OSORIO O, Butcher E, Erle D . Differential expression of homing molecules on recirculating lymphocytes from sheep gut, peripheral, and lung lymph. J Immunol. 1996; 156(9):3111-7. View

5.
Hieshima K, Kawasaki Y, Hanamoto H, Nakayama T, Nagakubo D, Kanamaru A . CC chemokine ligands 25 and 28 play essential roles in intestinal extravasation of IgA antibody-secreting cells. J Immunol. 2004; 173(6):3668-75. DOI: 10.4049/jimmunol.173.6.3668. View